, , , ,

A Drug Company Says This Shot Will Keep You Out of Prison – The Marshall Project

Johnson & Johnson has received FDA approval to promote Invega Sustenna as a drug that could potentially reduce the risk of incarceration for people with schizophrenia. Read more.

You might also like
NAMI and Partners Release New Report on Inadequate Health Plans – National Alliance of Mental Illness
Webinar: Fetal Alcohol Spectrum Disorder (FASD) and the Criminal Justice System: From Arrest to Community Supervision, March 2
A Popular Psychology Technique is Being Used to Reform the Prison System – Quartz
McCoy v. Louisiana: New Challenges for Defenders, New Risks for the Mentally Ill – The George Washington Law Review
This Teen Planned a School Shooting. But Did He Break the Law?
The Mental Health Crisis Facing Women in Prison – The Marshall Project
New Processing Technique Helps Researchers Use Electronic Health Records to Study Biological Contributors to Mental Illnesses – National Institute of Mental Health
Fetal Alcohol Disorder May Be Far More Common Than Previously Thought – Cleveland Clinic